Application of Quality by Design (Q-b-D) methodology for product commercialization is increasingly becoming the standard business practice at Pharma and Biotech companies. It is also much sought after by US and EU regulators as an approach presented in regulatory dossier to demonstrate that product will be safe and effective consistently over its lifecycle. While the concept of Quality by Design is universal and commonplace in many sectors, its application in Biotech industry for product commercialization is relatively new and “purpose-built” to suit the nuances of the products and processes.
|Click here to take the next step
to learn more and enroll
Or fill out the form to connect with a member of the BETC team to:
○ Learn about customized training opportunities on this topic for groups
○ Subscribe to updates from the BETC on this and other training opportunities